Table 4.
Pharmaceuticals | Classification | Proliferation | Apoptosis | Autophagy | Cell migration | Cell Invasion | Fibrosis | Angiogenesis | Oxidative stress | Immune and inflammation |
---|---|---|---|---|---|---|---|---|---|---|
Melatonin | Anxiolytic agent | ‐ | MMP‐3 63 | ‐ | ‐ | ‐ | ‐ | VEGF, MMP‐9 142 | ROS 143 | COX‐2 143 |
Metformin | Antidiabetic agent | ‐ | ‐ | ‐ | ‐ | Wnt2 48 | ‐ | ‐ | ‐ | Cytokines 149 |
NAC | Amino acid cysteine | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ROS 137 | Cytokines 144 |
Curcumin | Curcuminoid | ‐ | MMP‐3 81 | ‐ | ‐ | ‐ | ‐ | Chemokine and cytokines 253 | ‐ | Chemokine and cytokines 253 |
EGCG | Catechin | E2 167 | ‐ | ‐ | TGF β1 110 | TGF β1 110 | TGF β1 110 | VEGFR270, 129 | ROS 130 | ‐ |
TGF β1 110 | ||||||||||
VEGFR270, 129 | ||||||||||
Genistein | Isoflavone | ‐ | TGF‐β 85 | ‐ | NF‐κB 196 | NF‐κB 196 | ‐ | ‐ | ‐ | ‐ |
Ginsenoside | Steroid glycoside | TNF‐α 79 | TNF‐α 79 | ERα and PRα 103 | ‐ | ‐ | ‐ | TNF‐α 79 | ‐ | Induce NK cells toxicity 103 |
Puerarin | Isoflavone | ERs 93 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | P450AROM 152 |
Resveratrol | Phytoalexin | ESR1 66 | ‐ | ‐ | ‐ | ‐ | ‐ | Cytokines 150 | ROS 138 | Cytokines, 150 SIRT1 151 |
Abbreviations: AKT, protein kinase B; AMPK, adenosine monophosphate‐activated protein kinase; CASP, caspases; CHOP, CCAAT/enhancer‐binding protein homologous 10 protein; COX, cyclooxygenase; DPPH, 2,2‐diphenyl‐1‐picrylhydrazyl; E2, Estrogen; EGCG, epigallocatechin gallate; ER, estrogen receptor; ERK, extracellular signal‐regulated kinase; ESR1, estrogen receptor 1; HMGB1, high mobility group box 1; H2O2, hydrogen peroxide; IKKB, IκB kinase beta; MAPK, mitogen‐activated protein kinase; MMP, matrix metallopeptidases; NAC, N‐acetyl cysteine; NF‐κB, nuclear factor κB; NK cells, natural killer cells; NOD2, nucleotide‐binding oligomerization domain‐containing protein 2; Nrf2, nuclear factor erythroid 2–related factor 2; O2, oxygen; OH, hydroxide; P450AROM, aromatase; PI3K, phosphoinositide 3‐kinases; PR, progesterone receptor; REDD1, protein regulated in development and DNA damage response 1; ROS, reactive oxidative stress; SIRT1, sirtuin 1; TCM, traditional Chinese medicine; TGF, transforming growth factors; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor; Wnt, wingless‐type mouse mammary tumor virus integration site family.